Skip to main content
Log in

Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

We investigated the effects of lamotrigine, aripiprazole and escitalopram administration and experimental depression on lipid peroxidation (LP) and antioxidant levels in cortex of the brain in rats. Forty male wistar rats were randomly divided into five groups. First group was used as control although second group was depression-induced group. Aripiprazole, lamotrigine and escitalopram per day were orally supplemented to chronic mild stress (CMS) depression-induced rats constituting the third, fourth and fifth groups for 28 days, respectively. Depression resulted in significant decrease in the glutathione peroxidase (GSH-Px) activity, reduced glutathione and vitamin C of cortex of the brain although their levels and beta-carotene concentrations were increased by the three drugs administrations to the animals of CMS induced depression group. The LP levels in the cortex of the brain and plasma of depression group were elevated although their levels were decreased by the administrations. The increases of antioxidant values in lamotrigine group were higher according to aripiprazole and escitalopram supplemented groups. Vitamin A level did not change in the five groups. In conclusion, the experimental depression is associated with elevated oxidative stress although treatment with lamotrigine has most protective effects on the oxidative stress within three medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CMS:

Chronic mild stress

GSH-Px:

Glutathione peroxidase

GSH:

Glutathione

LP:

Lipid peroxidation

MAO:

Monoaminooxidase

MDA:

Malondialdehyde

PUFAs:

Polyunsaturated fatty acids

ROS:

Reactive oxygen species

SSRIs:

Selective- serotonin reuptake inhibitors

SOD:

Superoxide dismutase

References

  1. Halliwell B, Gutteridge JMC (1999) Free radicals, other reactive species and disease. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology, medicine, 3rd edn. Oxford University Press, New York, pp 639–645

    Google Scholar 

  2. Nazıroğlu M, Şimşek M, Kutlu M (2004) Moderate exercise with dietary vitamin C and E combination protects streptozotocin- induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 42:511–517

    Article  PubMed  Google Scholar 

  3. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51

    Article  PubMed  CAS  Google Scholar 

  4. Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111–127

    Article  PubMed  CAS  Google Scholar 

  5. Whanger PD (2001) Selenium and the brain: a review. Nutr Neurosci 4:81–97

    PubMed  CAS  Google Scholar 

  6. Thase ME (2005) Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 13:257–271

    Article  PubMed  Google Scholar 

  7. Maher P, Davis JB (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16:6394–6401

    PubMed  CAS  Google Scholar 

  8. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J (2004) Is low dietary intake of omega−3 fatty acids associated with depression? Am J Psychiatry 161:567–569

    Article  PubMed  Google Scholar 

  9. Rao JS, Ertley RN, Lee HJ, Demar JC Jr, Arnold JT, Rapoport SI, Bazinet RP (2006). n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 12:36–46

    Article  PubMed  Google Scholar 

  10. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 22:275–291

    Article  Google Scholar 

  11. Baydas G, Kutlu S, Nazıroğlu M, Canpolat S, Sandal S, Özcan M, Keleştimur H (2003) Inhibitory effects of melatonin on lipid peroxidation induced by intracerebroventricularly administered homocysteine. J Pineal Res 34:36–39

    Article  PubMed  CAS  Google Scholar 

  12. Nazıroğlu M. (2006). Effects of physical exercise with a dietary vitamins C and E combination on oxidative stress in muscle, liver and brain of streptozotocin- induced diabetic pregnant rat. In: Braunstain MH (ed), Vitamin E: New Research. Nova Science Publishers Inc, NY USA, pp 69–83

    Google Scholar 

  13. Özmen I, Naziroglu M, Alici HA, Sahin F, Cengiz M, Eren I (2007) Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem Res 32:19–25

    Article  PubMed  Google Scholar 

  14. Eren I, Nazıroğlu M, Demirdaş A, Çelik O, Uğuz AC, Altunbaşak A, Özmen I, Uz E (2007) Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32: (in press)

  15. Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, Matthews KA (2007) Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun 21:229–237

    Article  PubMed  CAS  Google Scholar 

  16. Andreasson A, Arborelius L, Erlanson-Albertsson C, Lekander M. (2007) A putative role for cytokines in the impaired appetite in depression. Brain Behav Immun 21:147–152

    Article  PubMed  CAS  Google Scholar 

  17. Kökçam İ, Nazıroğlu M (2002) Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet’s disease. Clin Biochem 35:633–639

    Article  PubMed  Google Scholar 

  18. Chen F, Larsen MB, Sanchez C, Wiborg O (2005) The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol 15:193–198

    Article  PubMed  CAS  Google Scholar 

  19. Patkar AA, Peindl K, Mago R, Mannelli P, Masand PS (2006). An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. Prim Care Companion J Clin Psychiatry 8:82–87

    PubMed  Google Scholar 

  20. Worthington JJ 3rd, Kinrys G, Wygant LE, Pollack MH. (2005). Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol 20:9–11

    Article  PubMed  Google Scholar 

  21. Bourin M, Masse F, Hascoet M (2005) Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. J Psychiatry Neurosci 30:275–282

    PubMed  Google Scholar 

  22. Grippo AJ, Moffitt JA, Johnson AK (2002). Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am J Physiol Regul Integr Comp Physiol 282:R1333–R1341

    PubMed  CAS  Google Scholar 

  23. Grippo AJ, Beltz TG, Johnson AK (2003) Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 78:703–710

    Article  PubMed  CAS  Google Scholar 

  24. Muscat R, Willner P (1992) Suppression of sucrose drinking by chronic mildunpredictable stress: a methodological analysis. Neurosci Biobehav Rev 16:507–517

    Article  PubMed  CAS  Google Scholar 

  25. Placer ZA, Cushman L, Johnson BC (1966) Estimation of products of lipid peroxidation (malonyl dialdehyde) in biological fluids. Anal Biochem 16:359–364

    Article  PubMed  CAS  Google Scholar 

  26. Sedlak J, Lindsay RHC (1968) Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’ s reagent. Anal Biochem 25:192–205

    Article  PubMed  CAS  Google Scholar 

  27. Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71:952–958

    Article  PubMed  CAS  Google Scholar 

  28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin-Phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  29. Suzuki J, Katoh N (1990) A simple and cheap method for measuring vitamin A in cattle using only a spectrophotometer. Jpn J Vet Sci 52:1282–1284

    Google Scholar 

  30. Jagota SK, Dani HM (1982) A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent. Anal Biochem 127:178–182

    Article  PubMed  CAS  Google Scholar 

  31. Sierra-Honigmann MR, Murphy PA. (1992) Suppression of interleukin−1 action by phospholipase-A2 inhibitors in helper T lymphocytes. Pept Res 5:258–261

    PubMed  CAS  Google Scholar 

  32. Nunez MJ, Balboa J, Rodrigo E, Brenlla J, Gonzalez-Peteiro M, Freire-Garabal M (2006) Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett 396:247–251

    Article  PubMed  CAS  Google Scholar 

  33. Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Tunckol H (2004) Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci 254:231–235

    PubMed  Google Scholar 

  34. Nieuwstraten C, Labiris NR, Holbrook A (2006) Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 51:300–316

    PubMed  Google Scholar 

  35. Yamada M, Yamada M, Yamazaki S, Takahashi K, Nara K, Ozawa H, Yamada S, Kiuchi Y, Oguchi K, Kamijima K, Higuchi T, Momose K (2001) Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci Lett 301:183–186

    Article  PubMed  CAS  Google Scholar 

  36. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A (2000) Lower serum vitamin E concentrations in major depression Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58:241–246

    Article  PubMed  CAS  Google Scholar 

  37. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493–4497

    Article  PubMed  CAS  Google Scholar 

  38. Czernichow S, Hercberg S (2001) Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases A review. J Nutr Health Aging 5:188–195

    PubMed  CAS  Google Scholar 

  39. Bolden-Watson C, Richelson E (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023–1029

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Authors wish to thank A. Cihangir Uğuz and Ömer Çelik for excellent help on the analysis of antioxidant parameters.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Nazıroğlu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eren, İ., Nazıroğlu, M. & Demirdaş, A. Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain. Neurochem Res 32, 1188–1195 (2007). https://doi.org/10.1007/s11064-007-9289-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-007-9289-x

Keywords

Navigation